Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.02 USD | +1.57% | +10.89% | -2.31% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 215M | |
+9.76% | 115B | |
+11.91% | 106B | |
-2.77% | 21.96B | |
-14.11% | 21.87B | |
-5.29% | 19.21B | |
-3.20% | 18.08B | |
-38.57% | 17.71B | |
+6.41% | 14.32B | |
+35.38% | 12.42B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14